Fas apoptotic inhibitor molecule 2 mitigates metabolic dysfunction-associated fatty liver disease through autophagic CRTC2 degradation
Authors:
Preprint
- 24 March 2025
- preprint
- Published by Springer Nature in Research Square
Abstract
Lysosomal membrane proteins (LMPs) play fundamental roles in the lysosomal degradation of proteins and are attractive drug targets for metabolic dysfunction-associated fatty liver disease (MAFLD). Fas apoptotic inhibitory molecule 2 (FAIM2), an LMP, is previously recognized as an inhibitor of apoptosis in a variety of diseases. Here, we reveal that FAIM2 is an inhibitor of fatty acid synthesis and suppresses MAFLD. FAIM2 protein expression is decreased in MAFLD. Moreover, FAIM2 is degraded by the E3 ubiquitin ligase NEDD4L through catalyzing K48-linked ubiquitination. High-fat or high-fat and high-cholesterol diet-induced hepatic steatosis, inflammation and fibrosis was aggravated in FAIM2 knockout (KO) mice and alleviated in FAIM2 overexpressing mice. Furthermore, in hepatocytes, FAIM2 KO increased the expression of genes related to fatty acid synthesis, whereas over-expressing FAIM2 exhibits the opposite effect. Mechanistically, FAIM2 directly interacts with CREB-regulated transcription coactivator 2 (CRTC2), a prominent regulator of lipid metabolism, and medicates its degradation through autophagy. Specifically, we find that the N-terminus of FAIM2 which interacts with CRCT2 and LC3B is required for autophagic CRTC2 degradation. Collectively, our findings reveal that FAIM2 acts as a fatty acid synthesis inhibitor in MAFLD by promoting the autophagic degradation of CRTC2, and FAIM2-CRTC2 may be a promising therapeutic target.Keywords
All Related Versions
This publication has 34 references indexed in Scilit:
- Changing epidemiology, global trends and implications for outcomes of NAFLDJournal of Hepatology, 2023
- A new perspective on NAFLD: Focusing on lipid dropletsJournal of Hepatology, 2022
- A novel role of CRTC2 in promoting nonalcoholic fatty liver diseaseMolecular Metabolism, 2021
- LAMP3 regulates hepatic lipid metabolism through activating PI3K/Akt pathwayMolecular and Cellular Endocrinology, 2018
- The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver DiseasesHepatology, 2017
- A novel role for CRTC2 in hepatic cholesterol synthesis through SREBP‐2Hepatology, 2017
- Common variants in BDNF, FAIM2, FTO, MC4R, NEGR1, and SH2B1 show association with obesity‐related variables in Spanish Roma populationAmerican Journal of Human Biology, 2014
- Lysosomal integral membrane protein-2: A new player in lysosome-related pathologyMolecular Genetics and Metabolism, 2014
- At the acidic edge: emerging functions for lysosomal membrane proteinsTrends in Cell Biology, 2003
- Neural Membrane Protein 35 (NMP35): A Novel Member of a Gene Family Which Is Highly Expressed in the Adult Nervous SystemMolecular and Cellular Neuroscience, 1998